Skip to main content
. 2020 Mar 5;40(3):327–338. doi: 10.1177/0272989X20907353

Figure 3.

Figure 3

The incremental net health benefit from (a) eliminating slow (A), low (B) and delayed (C) implementation; and (b) eliminating regional implementation variation (D), based on the ticagrelor case study.